JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209176200 on October 24, 2002

J. Biol. Chem., Vol. 277, Issue 52, 50491-50496, December 27, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/52/50491    most recent
M209176200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, G.
Right arrow Articles by Salen, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, G.
Right arrow Articles by Salen, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of the Farnesoid X Receptor (FXR) by Bile Acid Flux in Rabbits*

Guorong XuDagger §, Lu-xing Pan§, Hai Li§, Barry M. Forman||, Sandra K. Erickson**, Sarah Shefer§, Jaya Bollineni§, Ashok K. Batta§, Jennifer Christie§, Tsu-hong Wang§, John Michel§, Steve Yang§, Richard Tsai§, Lily Lai||, Kohei Shimada||, G. Stephen TintDagger §, and Gerald SalenDagger §

From the Dagger  Medical Service, Veterans Affairs Medical Center, East Orange, New Jersey 07018, the § Department of Medicine, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103, the || Department of Molecular Medicine, The City of Hope National Medical Center, Duarte, California 91010, and the ** Department of Medicine, University of California, San Francisco and the Veterans Affairs Medical Center, San Francisco, California 94121

We investigated the roles of hydrophobic deoxycholic acid (DCA) and hydrophilic ursocholic acid (UCA) in the regulation of the orphan nuclear farnesoid X receptor (FXR) in vivo. Rabbits with bile fistula drainage (removal of the endogenous bile acid pool), rabbits with bile fistula drainage and replacement with either DCA or UCA, and intact rabbits fed 0.5% cholic acid (CA) (enlarged endogenous bile acid pool) were studied. After bile fistula drainage, cholesterol 7alpha -hydroxylase (CYP7A1) mRNA and activity levels increased, FXR-mediated transcription was decreased, and FXR mRNA and nuclear protein levels declined. Replacing the enterohepatic bile acid pool with DCA restored FXR mRNA and nuclear protein levels and activated FXR-mediated transcription as evidenced by the increased expression of its target genes, SHP and BSEP, and decreased CYP7A1 mRNA level and activity. Replacing the bile acid pool with UCA also restored FXR mRNA and nuclear protein levels but did not activate FXR-mediated transcription, because the SHP mRNA level and CYP7A1 mRNA level and activity were unchanged. Feeding CA to intact rabbits expanded the bile acid pool enriched with the FXR high affinity ligand, DCA. FXR-mediated transcription became activated as shown by increased SHP and BSEP mRNA levels and decreased CYP7A1 mRNA level and activity but did not change FXR mRNA or nuclear protein levels. Thus, both hydrophobic and hydrophilic bile acids are effective in maintaining FXR mRNA and nuclear protein levels. However, the activating ligand (DCA) in the enterohepatic flux is necessary for FXR-mediated transcriptional regulation, which leads to down-regulation of CYP7A1.


* This study was supported by grants from the Department of Veterans Affairs Research Service, Washington, D. C. and National Institutes of Health Grants DK56830, HL18094, DK57636, DK26756, and HD20632.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: GI Lab (15A), Veterans Affairs Medical Center, 385 Tremont Ave., East Orange, NJ 07018-1095. Tel.: 973-676-1000 ext. 1452; Fax: 973-676-2991; E-mail: xugu@umdnj.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Jean-Louis, S. Akare, M. A. Ali, E. A. Mash Jr., E. Meuillet, and J. D. Martinez
Deoxycholic Acid Induces Intracellular Signaling through Membrane Perturbations
J. Biol. Chem., May 26, 2006; 281(21): 14948 - 14960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. K. Wu and D. E. Cohen
Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice
Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G456 - G461.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. A. Alrefai, Z. Sarwar, S. Tyagi, S. Saksena, P. K. Dudeja, and R. K. Gill
Cholesterol modulates human intestinal sodium-dependent bile acid transporter
Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G978 - G985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Li, F. Chen, Q. Shang, L. Pan, B. L. Shneider, J. Y. L. Chiang, B. M. Forman, M. Ananthanarayanan, G. S. Tint, G. Salen, et al.
FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G60 - G66.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Xu, L.-x. Pan, H. Li, Q. Shang, A. Honda, S. Shefer, J. Bollineni, Y. Matsuzaki, G. S. Tint, and G. Salen
Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G730 - G735.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Duran-Sandoval, G. Mautino, G. Martin, F. Percevault, O. Barbier, J.-C. Fruchart, F. Kuipers, and B. Staels
Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
Diabetes, April 1, 2004; 53(4): 890 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-L. Lew, A. Zhao, J. Yu, L. Huang, N. de Pedro, F. Pelaez, S. D. Wright, and J. Cui
The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
J. Biol. Chem., March 5, 2004; 279(10): 8856 - 8861.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Xu, H. Li, L.-x. Pan, Q. Shang, A. Honda, M. Ananthanarayanan, S. K. Erickson, B. L. Shneider, S. Shefer, J. Bollineni, et al.
FXR-mediated down-regulation of CYP7A1 dominates LXR{alpha} in long-term cholesterol-fed NZW rabbits
J. Lipid Res., October 1, 2003; 44(10): 1956 - 1962.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cui, L. Huang, A. Zhao, J.-L. Lew, J. Yu, S. Sahoo, P. T. Meinke, I. Royo, F. Pelaez, and S. D. Wright
Guggulsterone Is a Farnesoid X Receptor Antagonist in Coactivator Association Assays but Acts to Enhance Transcription of Bile Salt Export Pump
J. Biol. Chem., March 14, 2003; 278(12): 10214 - 10220.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.